Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Dec;31(12):1137-43.
doi: 10.1016/s1701-2163(16)34374-2.

Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy

Affiliations
Randomized Controlled Trial

Inadequacy of plasma acyclovir levels at delivery in patients with genital herpes receiving oral acyclovir suppressive therapy in late pregnancy

Daniel T Leung et al. J Obstet Gynaecol Can. 2009 Dec.

Abstract

Objective: Acyclovir therapy in late pregnancy among women with recurrent genital herpes is effective in decreasing genital lesion frequency and subclinical viral shedding rates at delivery, thereby decreasing the need for Caesarean section. Despite good adherence and increased dosing schedules, breakthrough lesions and viral shedding are still observed in some women at or near delivery. Anecdotal evidence suggests that low levels of herpes simplex virus replication at delivery may result in transmission to the neonate. Therefore, defining optimal acyclovir dosing during labour and delivery is warranted. Our objectives were to determine actual maternal and fetal acyclovir levels at delivery, and explore associations between acyclovir levels, duration of labour, and time since last acyclovir dose.

Methods: Twenty-seven patients were prescribed oral acyclovir 400 mg three times daily from 36 weeks' gestation. Cord blood (venous and arterial) and maternal venous blood samples were collected at delivery, and acyclovir levels measured using capillary electrophoresis. Correlations between duration of labour, and time since last acyclovir dose with acyclovir blood levels were calculated.

Results: Acyclovir levels were below the published mean steady-state trough value (180 ng/mL) in 52% of venous cord samples, 55% of arterial cord samples, and 36% of maternal samples. There was a significant inverse correlation between the time since last dose and venous cord levels (rs19 = -0.57, P < 0.015), arterial cord levels (rs16 = -0.63, P < 0.01), and maternal acyclovir levels (r10 = -0.69, P < 0.03).

Conclusion: Oral dosing of acyclovir in women in late pregnancy may result in insufficient levels at delivery to prevent viral shedding. Alternative approaches that incorporate acyclovir dosing through labour, either through oral or intravenous administration, should be evaluated to assess effects on viral shedding.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlational analyses between time since last dose of acyclovir and A) venous cord acyclovir levels, B) arterial cord acyclovir levels, and C) maternal acyclovir levels.

Similar articles

Cited by

References

    1. Fonnest G, Fonnest ID, Weber T. Neonatal herpes in Denmark 1977-1991. Acta Obstet Gynecol Scand. 1997;76(4):355–8. - PubMed
    1. Poeran J, Wildschut H, Gaytant M, Galama J, Steegers E, van der Meijden W. The incidence of neonatal herpes in The Netherlands. J Clin Virol. 2008;42(4):321–5. - PubMed
    1. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paed Perinatal Epidemiol. 1996;10(4):432–42. - PubMed
    1. Kropp RY, Wong T, Cormier L, Ringrose A, Burton S, Embree JE, Steben M. Neonatal herpes simplex virus infections in Canada: Results of a 3-year national prospective study. Pediatrics. 2006;117(6):1955–62. - PubMed
    1. Garland SM. Neonatal Herpes-Simplex - Royal-Womens-Hospital 10-Year Experience with Management Guidelines for Herpes in Pregnancy. Aust NZ J Obstet Gynaecol. 1992;32(4):331–4. - PubMed

Publication types

MeSH terms